Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XLV vs. RSPH: which is better?

Bottom line

XLV vs RSPH: the short answer

XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and RSPH (Invesco S&P 500 Equal Weight Health Care ETF) are quite different portfolios: only about 19% of their top holdings (by weight) are shared.

XLV is cheaper at 0.08% vs 0.4% — a difference of $32 a year per $10,000 invested.

Over five years, XLV returned +8.1% a year vs +4.7% for RSPH.

Updated Nov 19, 2026

XLV vs RSPH side by side

XLVRSPH
TypeETFETF
Fund familySPDR (State Street)Invesco
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.08%0.4%
Annual cost per $10k$8$40
10-yr cost on $10k (prospectus)$103$505
Max front loadNoneNone
12b-1 fee0.02%—
1-yr return+14.5%+9.3%
5-yr return (annualized)+8.1%+4.7%
10-yr return (annualized)+9.8%+8.2%
Best quarter+14.5%+17.5%
Worst quarter−12.7%−14.3%
Net assets (fund)$40.6B$766.9M
Number of holdings6563
Portfolio turnover2%24%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearXLVRSPHDifference
2025+14.5%+9.3%+5.2%
2024+2.5%−0.8%+3.3%
2023+2.0%+3.9%−1.9%
2022−2.1%−9.2%+7.2%
2021+25.9%+23.0%+2.9%
2020+13.3%+18.9%−5.6%
2019+20.7%+25.3%−4.7%
2018+6.3%−0.3%+6.6%
2017+21.7%+23.4%−1.7%
2016−2.8%−4.5%+1.7%

Source: Fund prospectus bar charts

Holdings overlap

7 of XLV's top 25 holdings also appear in RSPH's top 25.

Shared top holdings
HoldingXLVRSPH
AbbVie Inc7.74%1.73%
Amgen Inc3.40%1.77%
Thermo Fisher Scientific Inc3.24%1.84%
Abbott Laboratories2.75%1.83%
Bristol-Myers Squibb Co2.05%1.82%
Regeneron Pharmaceuticals Inc1.08%1.96%
Cencora Inc0.96%1.71%

Source: SEC Form N-PORT

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

RSPH top 10

  1. Bio-Techne Corp. — 2.13%
  2. IQVIA Holdings Inc. — 2.00%
  3. Baxter International Inc. — 1.99%
  4. Regeneron Pharmaceuticals, Inc. — 1.96%
  5. Mettler-Toledo International Inc. — 1.94%
  6. Charles River Laboratories International, Inc. — 1.93%
  7. Veeva Systems Inc. — 1.93%
  8. DaVita Inc. — 1.87%
  9. Moderna, Inc. — 1.85%
  10. Thermo Fisher Scientific Inc. — 1.84%

FAQ

What is the difference between XLV and RSPH?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and RSPH (Invesco S&P 500 Equal Weight Health Care ETF) are quite different portfolios: only about 19% of their top holdings (by weight) are shared. XLV is cheaper at 0.08% vs 0.4% — a difference of $32 a year per $10,000 invested.
Which is cheaper, XLV or RSPH?
XLV has the lower expense ratio (0.08%).
Should I own both XLV and RSPH?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.